Robert J Campbell1, Roseanne Sutherland2, Shahriar Khan2, Katharine M Doliszny2, Philip L Hooper2, Morgan Slater2, Eliot Frymire2, Baiju R Shah2, Jennifer D Walker2, Michael E Green2. 1. Department of Ophthalmology (Campbell, Doliszny), Queen's University and Kingston Health Sciences Centre; ICES Queen's (Campbell, Khan, Frymire, Walker, Green), Kingston, Ont.; Chiefs of Ontario (Sutherland), Toronto, Ont.; Department of Ophthalmology (Hooper), Western University and St. Joseph's Hospital, London, Ont.; Department of Family Medicine (Slater, Green) and Health Services and Policy Research Institute (Frymire), Queen's University, Kingston, Ont.; ICES Central (Shah); Department of Medicine (Shah), University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Ont.; School of Rural and Northern Health (Walker), Laurentian University, Sudbury, Ont. rob.campbell@queensu.ca. 2. Department of Ophthalmology (Campbell, Doliszny), Queen's University and Kingston Health Sciences Centre; ICES Queen's (Campbell, Khan, Frymire, Walker, Green), Kingston, Ont.; Chiefs of Ontario (Sutherland), Toronto, Ont.; Department of Ophthalmology (Hooper), Western University and St. Joseph's Hospital, London, Ont.; Department of Family Medicine (Slater, Green) and Health Services and Policy Research Institute (Frymire), Queen's University, Kingston, Ont.; ICES Central (Shah); Department of Medicine (Shah), University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Ont.; School of Rural and Northern Health (Walker), Laurentian University, Sudbury, Ont.
Abstract
BACKGROUND: In Canada, First Nations populations experience a higher incidence of diabetes and diabetes-related complications than other people. Given the paucity of information on use of preventive eye examinations and the need for interventional care for severe retinopathy among First Nations people, we carried out a population-based study to compare rates of eye examinations and interventional therapies to treat vision-threatening stages of diabetic retinopathy among First Nations people and other people with diabetes in Ontario. METHODS: In collaboration with the Chiefs of Ontario, we carried out a population-based study to identify cohorts of First Nations people and other people with diabetes in Ontario from 1995/96 to 2014/15. We used linked health administrative databases to evaluate rates of eye examination (2005/06-2014/15) and severe diabetic retinopathy treatment and compared them between the 2 populations, and between First Nations people living in and outside of First Nations communities. RESULTS: We identified 23 013 First Nations people and 1 364 222 other people diagnosed with diabetes from 1995/96 to 2014/15, of whom 49.8% (95% confidence interval [CI] 48.9%-50.7%) and 53.8% (95% CI 53.7%-54.0%), respectively, received an eye examination in 2014/15. Eye examination rates were similar for First Nations people regardless of whether they lived in or outside a First Nations community. First Nations people developed severe diabetic retinopathy at a faster rate than other people (hazard ratio 1.19, 95% CI 1.02-1.38). The gap between First Nations people and other people in the proportion requiring therapy for severe diabetic retinopathy was especially prominent among younger people. There were no significant differences in rates of diabetic retinopathy treatment in First Nations people stratified by place of residence. INTERPRETATION: Eye examination rates remain suboptimal among people with diabetes in Ontario and were lower among First Nations people. This is particularly concerning in light of our other findings showing an increased risk of requiring treatment for advanced diabetic retinopathy and the accelerated rate of diabetic retinopathy progression among First Nations people with diabetes. Copyright 2020, Joule Inc. or its licensors.
BACKGROUND: In Canada, First Nations populations experience a higher incidence of diabetes and diabetes-related complications than other people. Given the paucity of information on use of preventive eye examinations and the need for interventional care for severe retinopathy among First Nations people, we carried out a population-based study to compare rates of eye examinations and interventional therapies to treat vision-threatening stages of diabetic retinopathy among First Nations people and other people with diabetes in Ontario. METHODS: In collaboration with the Chiefs of Ontario, we carried out a population-based study to identify cohorts of First Nations people and other people with diabetes in Ontario from 1995/96 to 2014/15. We used linked health administrative databases to evaluate rates of eye examination (2005/06-2014/15) and severe diabetic retinopathy treatment and compared them between the 2 populations, and between First Nations people living in and outside of First Nations communities. RESULTS: We identified 23 013 First Nations people and 1 364 222 other people diagnosed with diabetes from 1995/96 to 2014/15, of whom 49.8% (95% confidence interval [CI] 48.9%-50.7%) and 53.8% (95% CI 53.7%-54.0%), respectively, received an eye examination in 2014/15. Eye examination rates were similar for First Nations people regardless of whether they lived in or outside a First Nations community. First Nations people developed severe diabetic retinopathy at a faster rate than other people (hazard ratio 1.19, 95% CI 1.02-1.38). The gap between First Nations people and other people in the proportion requiring therapy for severe diabetic retinopathy was especially prominent among younger people. There were no significant differences in rates of diabetic retinopathy treatment in First Nations people stratified by place of residence. INTERPRETATION: Eye examination rates remain suboptimal among people with diabetes in Ontario and were lower among First Nations people. This is particularly concerning in light of our other findings showing an increased risk of requiring treatment for advanced diabetic retinopathy and the accelerated rate of diabetic retinopathy progression among First Nations people with diabetes. Copyright 2020, Joule Inc. or its licensors.
Authors: Anthony J G Hanley; Stewart B Harris; Mary Mamakeesick; Ken Goodwin; Edith Fiddler; Robert A Hegele; J David Spence; Andrew A House; Ed Brown; Blair Schoales; John R McLaughlin; Ronald Klein; Bernard Zinman Journal: Diabetes Care Date: 2005-08 Impact factor: 19.112
Authors: Andrew J Jin; David Martin; David Maberley; Keith G Dawson; David W Seccombe; Joyce Beattie Journal: Int J Circumpolar Health Date: 2004 Impact factor: 1.228
Authors: Michael E Green; Baiju R Shah; Morgan Slater; Shahriar Khan; Carmen R Jones; Jennifer D Walker Journal: CMAJ Date: 2020-08-17 Impact factor: 8.262
Authors: Michael E Green; Baiju R Shah; Morgan Slater; Shahriar Khan; Carmen R Jones; Jennifer D Walker Journal: CMAJ Date: 2020-08-17 Impact factor: 8.262